Results

Total Results: 1,571 records

Showing results for "discussed".

141. Mobile Health Technology for Diabetes (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-mobile-devices_research-protocol.pdf
     July 12, 2017 - As discussed in the previous section, we will use a hierarchical approach to reviewing the evidence, … These challenges will be discussed with key informants and other topic experts to identify which challenges

142. Disposition of Comments Report for Core Needle and Open Surgical Biopsy for Diagnosis of Breast Lesions: An Update to the 2009 Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-biopsy-update_disposition-comments.pdf
     September 10, 2014 - We believe we have discussed this finding adequately and have highlighted it in the Report’s Abstract … We have discussed in general terms the choice among alternative biopsy methods. … Although policy implications are not discussed directly, they are evident. Thank you. … The relevance of the key questions vis a vis current American practice has been discussed above. … The selection of studies was appropriate, given the caveats about selection criteria discussed above

143. Disposition of Comments for CER 176 Management of Gout (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/gout-management-disposition-160721.pdf
     March 15, 2016 - ES-2, line 15: Regarding the management that is discussed about gout (as opposed to “chronic gout”). … The IL-1 antagonists should be discussed as the treatments for gout; they are not used to lower urate … TEP Reviewer #3 Results Full Report:• Page 34 of 176: IL-1B antagonists should not be discussed under … management of hyperuricemia; they should be discussed under management of gout attacks. … I believe that this is what rheumatologists and the FDA have been doing as discussed above.

144. Disposition of Comments Report for Evaluation and Treatment of Cryptorchidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/undescended-testicle_disposition-comments.pdf
     December 11, 2012 - and patient centered) outcome of paternity rates for those desiring offspring, they should still be discussed … We note the theoretical harms of treatment, and have discussed harms when they are reported. … These limitations will be discussed further below.

145. Module IV- Skills for Successful Engagement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/module-iv-skills-for-successful-engagement.pdf
     May 29, 2025 - Module IV- Skills for Successful Engagement …

146. Table 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-indicators-symposium_research.pdf
     April 01, 2010 - None of the authors has a financial interest in any of the products discussed in this report. … The group primarily discussed communication in the form of verbal conversations or family conferences

147. Disposition of Comments_Comparative Effectiveness Review No. 271, Treatments for Maternal Mental Health Conditions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-271-mental-health-pregnant-disposition-comments.pdf
     July 31, 2024 - All inclusion and exclusion criteria were discussed with a panel of technical experts and the review

148. Disposition of Comments Report for Prevention of Healthcare-Associated Infections (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/health-careassociated-infections_disposition-comments.pdf
     November 30, 2012 - reference 15 - but additional verbiage describing this section- including Table ES7 - reference 15 is not discussed … results overview section on pages ES-9 and 27. 55 TEP #1 Executive Summary ES-22 line 12 - " as discussed … Limitations are clearly discussed.

149. Disposition of Comments Report for Imaging Techniques for the Diagnosis and Staging of Hepatocellular Carcinoma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/liver-cancer_disposition-comments.pdf
     October 23, 2014 - the complex issue of staging HCC and [remainder of comment missing] Staging systems for HCC are discussed … These should be discussed, including the potential impact for more standardization. … discussion it is not explicitly stated Limitations of contrast-enhanced US for surveillance are discussed … In addition, imaging modalities are discussed.

150. Disposition of Comments Report for The Clinical Utility of Fractional Exhaled Nitric Oxide (FeNO) in Asthma Management (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-197-fractional-exhaled-nitric-oxide-disposition-comments.pdf
     December 20, 2017 - of these factors can enormously confound the studies in relation to asthma diagnosis and should be discussed … I have listed some specific issues below some of which relate to the general issue discussed above. … is usually low in obese patients and although this is mentioned in a line statement, nothing was discussed

151. Multidisciplinary Postacute Rehabilitation for Moderate to Severe Traumatic Brain Injury in Adults Disposition of Comments (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation_disposition-comments.pdf
     October 07, 2012 - While on P2 long-term disability after severe TBI is acknowledged, it is not discussed or incorporated … When no eligible studies used the MPAI-4, we discussed how MCID was addressed in eligible studies … outcomes, study designs, and risk of bias were adequately justified and their consequences appropriately discussed … The trajectory of improvement is discussed in the first paragraph on pg 56.

152. Disposition of Comments for PCA3 Testing for the Diagnosis and Management of Prostate Cancer (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_disposition-comments.pdf
     April 01, 2013 - However, the limitations of study quality and strength of evidence have been discussed, along with … This cannot be answered by this review, and that is discussed in the manuscript. … This is not discussed in the Results. … This issue was discussed by the review team and it was decided that the abstract and poster: 1) did … This cannot be answered by this review, and that is discussed in the manuscript.

153. Venous Thromboembolism Prophylaxis in Major Orthopedic Surgery: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/thromboembolism-update-disposition.pdf
     June 22, 2017 - Inclusion and exclusion criteria are discussed in a straight forward manner and are justifiable. … Disagreements were discussed within the team. Was there a process for this? Was it consensus? … The lack of evidence about most outcomes is problematic, as discussed. … These deficiencies are discussed in the Limitations part of the Discussion. … Limitations are discussed. No important literature that I know of has been omitted.

154. Disposition of Comments for Interventions To Improve Cardiovascular Risk Factors in People With Serious Mental Illness (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_disposition-comments.pdf
     April 22, 2013 - KQ 4 Our research team discussed this recommendation extensively and decided to keep the current … c) Our research team discussed this recommendation extensively and decided to keep the current structure

155. Disposition of Comments Report for Primary Care Management of Abnormal Uterine Bleeding (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_disposition-comments.pdf
     March 21, 2013 - suggestion that increased risk of thrombosis may be an example of confounding by indication is further discussed … the quality of some of the studies due to the reliance on patient reported or recorded outcomes is discussed … The authors discussed not only the applicability of the findings summaries, but also possible limitations … In one section” progesterone” is discussed in a more limited fashion but elsewhere almost all progesterone

156. EHC Protocol - Allocation of Scarce Resources During Pandemics: Strategies for Policy Makers: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/scarce-resources-protocol.pdf
     January 01, 2013 - of the findings was assessed, and (5) potential confounders to the strategy’s effectiveness were discussed

157. Comparative Effectiveness Research Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disabilities-quality-improvement-outcomes_disposition-comments.pdf
     October 15, 2012 - Disability” is used it would be more precise to state whether impairment or activity limitation is being discussed … Discussion of consensus building processes to narrow the field of outcome measures were discussed with

158. Using Collaborative Platforms for Communities of Practice (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/grama.pdf
     May 29, 2025 - Using Collaborative Platforms for Communities of Practice INNOVATIONS CONFERENCE -- NATIONAL CANCER INSTITUTE SPEAKER: LAKSHMI GRAMA, SENIOR DIGITAL CONTENT STRATEGIST, NATIONAL CANCER INSTITUTE (NCI) GRAMA: I’m Lakshmi Grama from the Office of Communications and Education at the National …

159. Medical Therapies for Children With Autism Spectrum Disorder—An Updaterum Disorder--An Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/asd-medical-disposition.pdf
     May 26, 2017 - The limited data on most of the medications discussed, and the potential for possible harm associated … Cochrane)and discussed why the results of those reviews might differ from the AHRQ.

160. Slide 1 (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/module_iv1.ppt
     May 29, 2025 - Slide 1 Engaging Stakeholders in the Effective Health Care Program Information and tools for researchers and investigators Numeric